Abstract
For a body of work to eventually be designated as a “Landmark” article may require years of analysis, further investigative support, and frequent citations in future articles. In this issue of Current Neurovascular Research, we are introducing the publication of pioneering original articles in combination with “state-of the-art” review articles that may someday be considered significant building blocks for future lines of investigation. In several respects, the articles focus upon the ability of ischemic cell injury to not only lead to acute or chronic nervous system impairment in a variety of disorders, but also to actively generate reparative processes that may even result from activities considered as simple as physical exercise.
Current Neurovascular Research
Title: From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease
Volume: 1 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Abstract: For a body of work to eventually be designated as a “Landmark” article may require years of analysis, further investigative support, and frequent citations in future articles. In this issue of Current Neurovascular Research, we are introducing the publication of pioneering original articles in combination with “state-of the-art” review articles that may someday be considered significant building blocks for future lines of investigation. In several respects, the articles focus upon the ability of ischemic cell injury to not only lead to acute or chronic nervous system impairment in a variety of disorders, but also to actively generate reparative processes that may even result from activities considered as simple as physical exercise.
Export Options
About this article
Cite this article as:
Maiese Kenneth, From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease, Current Neurovascular Research 2004; 1 (5) . https://dx.doi.org/10.2174/1567202043361947
DOI https://dx.doi.org/10.2174/1567202043361947 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
Current Neurovascular Research α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease
Current Drug Targets Relevant Modulation by Ferrous Ions of N-Methyl-D-Aspartate Receptors in Ischemic Brain Injuries
Current Neurovascular Research Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry Differences Between Parkinson’s and Huntington’s Diseases and Their Role for Prioritization of Stem Cell-Based Treatments
Current Molecular Medicine Multi-Target Compounds Acting in the Central Nervous System Designed From Natural Products
Current Medicinal Chemistry Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets An Update on Prion Biology and Proteomics
Current Proteomics Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease
Current Pharmaceutical Design Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways
Current Molecular Medicine Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets TRPM6 and TRPM7: A Mul-TRP-PLIK-Cation of Channel Functions
Current Pharmaceutical Biotechnology Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Current Alzheimer Research Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Current Drug Targets Protein Misfolding and Aggregation in Alzheimer's Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets